M Holdings Securities, Inc. Ocugen, Inc. Transaction History

M Holdings Securities, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 24, 2022	SELL	$2.34 - $4.72 $127,529 - $257,240	-54,500 Closed	0 $0
Q2 2021 Aug 19, 2021	BUY	$5.52 - $15.68 $300,840 - $854,560	54,500 New	54,500 $438,000

32.8M

518K

345K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $379M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on M Holdings Securities, Inc. with notifications on news.